DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

Incyte Corp (NASDAQ: INCY)

107.68 -0.73 (-0.67%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

INCY $107.68 -0.67%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $108.00
Previous Close $108.41
Daily Range $107.19 - $109.11
52-Week Range $43.86 - $111.93
Market Cap $19.3B
P/E Ratio -570.58
Dividend (Yield) $0.00 (0.0%)
Volume 694,683
Average Daily Volume 1,219,780
Current FY EPS -$0.23




Drug Makers

Incyte Corp (INCY) Description

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. Website:

News & Commentary

3 Growth Stocks Near 52-Week Highs Worth Selling

Just because these stocks are near their highs doesn't mean you should hang on to them.

Why Agenus Can Continue To Rise After Doubling

Fire Up the Immune System to Fight Cancers and Boost Portfolios: John McCamant

HyperAcute Pancreas Will Go To The Wire

Why These 4 Biotech Stocks Could Be the Next Buyout Targets

Incyte Posts Wider-than-Expected Q1 Loss, Jakafi Grows - Analyst Blog

Incyte (INCY) Earnings Report: Q1 2015 Conference Call Transcript

Incyte (INCY) Hervé Hoppenot on Q1 2015 Results - Earnings Call Transcript

3 Stable Large-Cap Biotech Stocks to Buy Now - Analyst Blog

Why Agenus Inc. Shares Surged Higher In Early Trading Today

Agenus Inc. shares jumped sharply on positive data for a shingles vaccine that uses its QS-21 Stimulon.

See More INCY News...

INCY's Top Competitors

INCY $107.68 (-0.67%)
Current stock: INCY
AMGN $163.59 (-0.15%)
Current stock: AMGN
GILD $111.71 (0.44%)
Current stock: GILD
BIIB $398.68 (-0.62%)
Current stock: BIIB